Unknown

Dataset Information

0

First Clinical Isolation of an Azole-Resistant Aspergillus fumigatus Isolate Harboring a TR46 Y121F T289A Mutation in South America.


ABSTRACT: One of the most recently described Aspergillus fumigatusCYP51A-mediated azole resistance mechanisms is TR46 Y121F T289A. Clinical A. fumigatus strains harboring these substitutions have been reported worldwide, with the exception of South America. We describe the first clinical A. fumigatus strain with this resistance mechanism isolated from an Argentinian patient. The strain was isolated in 2009 (1 year after the first-described mutant in United States), demonstrating that these alleles were scattered worldwide earlier than previously thought.

SUBMITTER: Isla G 

PROVIDER: S-EPMC6153829 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

First Clinical Isolation of an Azole-Resistant Aspergillus fumigatus Isolate Harboring a TR46 Y121F T289A Mutation in South America.

Isla Guillermina G   Leonardelli Florencia F   Tiraboschi Iris N IN   Refojo Nicolás N   Hevia Alejandra A   Vivot Walter W   Szusz Wanda W   Córdoba Susana B SB   García-Effron Guillermo G  

Antimicrobial agents and chemotherapy 20180924 10


One of the most recently described <i>Aspergillus fumigatus</i><i>CYP51A</i>-mediated azole resistance mechanisms is TR46 Y121F T289A. Clinical <i>A. fumigatus</i> strains harboring these substitutions have been reported worldwide, with the exception of South America. We describe the first clinical <i>A. fumigatus</i> strain with this resistance mechanism isolated from an Argentinian patient. The strain was isolated in 2009 (1 year after the first-described mutant in United States), demonstratin  ...[more]

Similar Datasets

| S-EPMC3421523 | biostudies-literature
| S-EPMC3647519 | biostudies-literature
| S-EPMC4649223 | biostudies-literature
| S-EPMC3421863 | biostudies-literature
| S-EPMC4432157 | biostudies-literature
| S-EPMC4468681 | biostudies-literature